Exchange: NASDAQ·Updated 07:25 PM EDT
BRTX logo

BRTXBioRestorative Therapies Inc

$0.3225
$0.0005
(0.15%)
Today
Closed $0.3225
$0.00
(0.00%)
After Hours
Mkt Cap$8.2M
Vol131,788.00
News
all
press releases
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers OSR Health (NASDAQ:OSRH) stock increased by 7.2% to $0.33 during Wednesday's after-market session. The company's market cap stands at $11.0 million. BioRestorative Therapies (NASDAQ:BRTX) stock movedread more...
Benzinga
More News
Kaos Capital Announces Acquisition of 4.9% Stake in BioRestorative Therapies (NASDAQ: BRTX)
Kaos Capital Announces Acquisition of 4.9% Stake in BioRestorative Therapies (NASDAQ: BRTX) Kaos Capital Announces Acquisition of 4.9% Stake in BioRestorative Therapies (NASDAQ: BRTX) PR Newswire MIAMI, May 27, 2026 Urgently seeks meeting with the BRTX Board to discuss opportunities to unlock value...
PR Newswire
What Makes Biorestorative Therapies (BRTX) a New Buy Stock
Biorestorative Therapies (BRTX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks
Biorestorative Therapies, Inc. (BRTX) Reports Q1 Loss, Misses Revenue Estimates
Biorestorative Therapies (BRTX) delivered earnings and revenue surprises of +36.67% and -53.66%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Coherus Oncology (CHRS) Reports Q1 Loss, Lags Revenue Estimates
Coherus Oncology (CHRS) delivered earnings and revenue surprises of -38.89% and -14.37%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
PTC Therapeutics (PTCT) Reports Q1 Loss, Tops Revenue Estimates
PTC Therapeutics (PTCT) delivered earnings and revenue surprises of +93.35% and +16.63%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Geron (GERN) Reports Q1 Loss, Beats Revenue Estimates
Geron (GERN) delivered earnings and revenue surprises of +60.00% and +2.94%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Here's Why Biorestorative Therapies (BRTX) Looks Ripe for Bottom Fishing
Biorestorative Therapies (BRTX) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Zacks
BioRestorative Therapies (OTCMKTS:BRTXQ) Trading 5.7% Higher - Here's Why
BioRestorative Therapies (OTCMKTS:BRTXQ) Trading 5.7% Higher - What's Next...
MarketBeat
BioRestorative Therapies (OTCMKTS:BRTXQ) Stock Price Down 4.5% - Here's What Happened
BioRestorative Therapies (OTCMKTS:BRTXQ) Shares Down 4.5% - What's Next...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.